Logo image of FWBI

FIRST WAVE BIOPHARMA (FWBI) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:FWBI - US33749P4081 - Common Stock

2.96 USD
+0.13 (+4.59%)
Last: 5/16/2024, 8:00:00 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to FWBI. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 36.72. This target is 1140.54% above the current price.
FWBI was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FWBI.
In the previous month the buy percentage consensus was at a similar level.
FWBI was analyzed by 8 analysts. More opinions would make the average more meaningful.
FWBI Historical Analyst RatingsFWBI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -88 -80 -72 -64 -56 -48 -40 -32 -24 -16 -8 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.9636.3636.7236.7237.80 - 1,128.38% 1,140.54% 1,140.54% 1,177.03%
FWBI Current Analyst RatingFWBI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-03-25 HC Wainwright & Co. Reiterate Neutral
2024-03-15 Roth MKM Maintains Buy -> Buy
2024-01-03 Roth MKM Maintains Buy -> Buy
2023-09-19 Roth MKM Reiterate Buy -> Buy
2023-07-14 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-06-29 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-13 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-04-26 HC Wainwright & Co. Reiterate Buy
2023-04-05 HC Wainwright & Co. Maintains Buy
2023-03-09 HC Wainwright & Co. Reiterate Buy
2023-02-03 HC Wainwright & Co. Reiterate Buy
2023-01-31 HC Wainwright & Co. Reiterate Buy
2023-01-26 HC Wainwright & Co. Reiterate Buy
2022-12-02 HC Wainwright & Co. Maintains Buy
2022-05-26 Roth Capital Maintains Buy
2021-12-07 Maxim Group Downgrade Buy -> Hold

FIRST WAVE BIOPHARMA / FWBI FAQ

What is the average price target for FIRST WAVE BIOPHARMA (FWBI) stock?

8 analysts have analysed FWBI and the average price target is 36.72 USD. This implies a price increase of 1140.54% is expected in the next year compared to the current price of 2.96.


What is the consensus rating for FWBI stock?

The consensus rating for FIRST WAVE BIOPHARMA (FWBI) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed FIRST WAVE BIOPHARMA (FWBI)?

The number of analysts covering FIRST WAVE BIOPHARMA (FWBI) is 8.